Friedman Bart 4
4 · Ovid Therapeutics Inc. · Filed Jun 8, 2018
Insider Transaction Report
Form 4
Friedman Bart
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-07+5,813→ 5,813 totalExercise: $8.12Exp: 2028-06-06→ Common Stock (5,813 underlying)
Footnotes (1)
- [F1]The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date.